Karachi, Glaxo Smith Kline Pakistan Limited informed Pakistan Stock Exchange that board of directors meeting of the company will be held on August 24, 2021 at Karachi. The agenda of the meeting will to consider the half yearly Accounts for the period ended June 30, 2021.
Further, the company has declared the closed period from August 17, 2021 to August 24, 2021.
GlaxoSmithKline Pakistan Limited was created January 1st, 2001 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan (Private) Limited and Glaxo Welcome (Pakistan) Limited and stands today as a pharmaceutical company in Pakistan.
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company and. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline Plc, UK (GSK Plc). GSK Pakistan operates mainly in two industry segments: Pharmaceuticals and consumer healthcare.
The share of the Company are 318,467,278. The Earnings per shares of the company is 10.60 in 2020 which was 9.55 in 2019. The profit after taxation is Rs. 3,375,240,000 in 2020 which was 3,041,123,000 in 2019.